Back to discover
Disease
Amebiasis
Late-stage therapeutic developmentEmerging research
1
Publications
1
Clinical trials
2023
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
Research2023-07-21International journal of molecular sciences
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
No activity recorded in this window. Try a wider timeframe.
Clinical trials
The current development programme across all trial phases.
Clinical programme
1
0
1
1
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Most influential
Major themes4
- Amebiasis1
- Dysentery, Amebic1
- Entamoeba1
- Entamoeba histolytica1
Leading journals1
- International journal of molecular sciences1
Leading researchers8
- González E1
- Hernández EG1
- Morán P1
- Padilla MLA1
- Pérez-Juárez H1
- Portillo-Bobadilla T1
- Ramiro M1
- Rojas-Velázquez L1
Affiliations (unnormalised)2
- Laboratorio de Inmunología1
- Universidad Nacional Autónoma de México (UNAM)-Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán1
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
Infection with any of various amebae. It is an asymptomatic carrier state in most individuals, but diseases ranging from chronic, mild diarrhea to fulminant dysentery may occur.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.